Questcor (QCOR) Resumes Trading, Bouncing Off of Lows
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Questcor Pharmacueticals (QCOR) Slammed 34% On Reports Aetna Insurance Coverage Dropped
September 19, 2012 10:29 AM EDTQuestcor Pharmacueticals, Inc. (NASDAQ: QCOR) is now down 34 percent on reports from Citron Research that Aetna dropped coverage of key drug Acthar.
According to Cintron:
One of the largest managed care providers in the United States, Aetna has disclosed that... More
Questcor Pharmaceuticals (QCOR) Slammed after Citron Notes Aetna Drops Acthar Coverage
September 19, 2012 10:13 AM EDTQuestcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is seeing downside after Citron Research notes that Aetna (NYSE: AET) is dropping coverage of key drug Acthar.
According to Cintron:
One of the largest managed care providers in the... More
